Drugs Health Pharma

One billion people globally are suffering from obesity, says  WHO

HQ Team March 1, 2024: More than one billion people worldwide are living with obesity and the disease has quadrupled among children and.

Read More
Drugs Health Medical

Unveiling the impact of fasting diets on eating behaviors, sleep, and mood

HQ Team January 29, 2024: Fasting diets (FDs) have gained popularity for their impact on health, disease, and weight control. Despite the vast.

Read More
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drug 

HQ Team December 22, 2023: The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

Read More
Drugs Health Pharma

Lilly to build $2.5b plant in Germany to make diabetes, obesity devices

HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.

Read More
Drugs Health Medical

Role of fructose in obesity, a new perspective

HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.

Read More
Drugs Health Pharma

Weight-loss drug mimicking exercise may help treat obesity, diabetes

HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the.

Read More
Drugs Health Pharma

Novo Nordisk’s weight-loss drug Wegovy enters the UK market 

HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.

Read More
Drugs Health Pharma

Obese people have different ‘appetite control centre’ in brain

HQ Team August 9, 2023: The brain’s hypothalamus gland is a relevant factor in obesity and little is known about how this region.

Read More
Drugs Health Pharma

Eli Lilly to acquire Versanis for $1.9 billion in an obesity drug push

HQ Team July `4, 2023: Eli Lilly and Company will acquire private Versanis for $ 1.93 billion in cash to expand its portfolio.

Read More